Angle (AGL) RNS Announcements

Add to Alert list
Date Time Source Announcement
30 Jun 2025 05:50 PM
RNS
Result of 2025 Annual General Meeting
17 Jun 2025 07:00 AM
RNS
EACR 2025: Innovation in AR expression profiling
17 Jun 2025 07:00 AM
RNS
EACR 2025: Data demonstrating DNA dual analysis
10 Jun 2025 07:00 AM
RNS
Novel discoveries into the biology of cancer
09 Jun 2025 07:00 AM
RNS
POSTING OF ANNUAL REPORT AND NOTICE OF AGM
06 Jun 2025 07:00 AM
RNS
Board Changes
28 May 2025 07:00 AM
RNS
Preliminary Results
23 May 2025 07:00 AM
RNS
Notice of Results
28 Apr 2025 07:00 AM
RNS
RESULTS SUPPORTING ANGLE’S HER2 ASSAY PROGRAMME
21 Mar 2025 07:00 AM
RNS
Issue of LTIP Options and Share Options
21 Mar 2025 07:00 AM
RNS
Results of Eisai Phase 2 pilot study
06 Feb 2025 07:00 AM
RNS
Novel findings using Parsortix
29 Jan 2025 07:00 AM
RNS
Analysis of CTC-DNA and ctDNA using Illumina assay
24 Jan 2025 10:05 AM
RNS
Parsortix used in research paper from ETH Zurich
23 Jan 2025 07:00 AM
RNS
Trading Update
13 Dec 2024 08:43 AM
RNS
HER2 presentation at SABCS
15 Nov 2024 07:00 AM
RNS
Research on HER2 assay kit showcased at AACR
15 Nov 2024 07:00 AM
RNS
Parsortix based PD-L1 assay showcased at AACR
13 Nov 2024 07:00 AM
RNS
ANGLE presents two posters at EACR
11 Nov 2024 07:00 AM
RNS
Parsortix enriched CTC & ctDNA in NSCLC patients
17 Oct 2024 07:00 AM
RNS
Publication demonstrates CTC profiling potential
26 Sep 2024 07:01 AM
RNS
100th publication supporting Parsortix system use
26 Sep 2024 07:00 AM
RNS
Half-year Report
23 Sep 2024 07:00 AM
RNS
Exclusive agreement for DNA NGS panel
19 Sep 2024 07:00 AM
RNS
Agreement with Recursion Pharmaceuticals
17 Sep 2024 07:00 AM
RNS
Notice of Interim Results and Webcast
22 Aug 2024 07:00 AM
RNS
Data supporting FDA approval published in Journal
01 Aug 2024 07:00 AM
RNS
Independent Parsortix study
18 Jul 2024 10:08 AM
RNS
Standard form for notification of major holdings
12 Jul 2024 03:38 PM
RNS
Standard form for notification of major holdings
11 Jul 2024 03:07 PM
RNS
Result of 2024 Annual General Meeting
11 Jul 2024 03:07 PM
RNS
Result of 2024 Annual General Meeting
21 Jun 2024 07:00 AM
RNS
Result of open offer
18 Jun 2024 02:41 PM
RNS
Posting of 2023 Annual Report & Notice of the AGM
11 Jun 2024 07:00 AM
RNS
Parsortix and assays being showcased at EACR 2024
06 Jun 2024 04:37 PM
RNS
Publication of Circular
05 Jun 2024 04:04 PM
RNS
Results of placing and subscription
05 Jun 2024 07:00 AM
RNS
Proposed Placing, Subscription and Open Offer
05 Jun 2024 07:00 AM
RNS
Preliminary Results
16 May 2024 07:00 AM
RNS
Study of ovarian cancer CTCs using Parsortix
03 May 2024 07:00 AM
RNS
New commercial agreement with large pharma
24 Apr 2024 07:00 AM
RNS
New commercial agreement with AstraZeneca
22 Apr 2024 07:00 AM
RNS
US and EU patents for innovative CellKeep™ slide
08 Apr 2024 07:00 AM
RNS
Parsortix HER2 assay showcased at AACR 2024
22 Mar 2024 07:00 AM
RNS
Parsortix at European breast cancer conference
22 Jan 2024 07:00 AM
RNS
Potential utility in precision oncology
10 Jan 2024 12:57 PM
RNS
Standard form for notification of major holdings
04 Jan 2024 07:00 AM
RNS
Breakthrough clinical results
02 Jan 2024 07:00 AM
RNS
Contract announcement with Eisai Inc.
11 Dec 2023 07:00 AM
RNS
Broker Announcement

ANGLE PLC is a commercially driven specialist medical diagnostic company with pioneering products in cancer diagnostics and foetal health. The Company's product includes Parsortix cell separation system.

Founded in 1994, AGL share price listed on LSE in 2004 under the ticker AGL.

UK 100

Latest directors dealings